Scott W Morrison
CIK 1662426 · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.08M
Companies
7
Total Filings
60
Lifetime Open-Market Net
-$860.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARS | Director | 13,654 | $65.33 | $892.0K | $0 | 11 | 2026-06-29 |
| ZLAB | Director | 56,904 | $20.88 | $1.19M | -$715.1K | 6 | 2026-06-22 |
| IDYA | Director | — | $36.24 | — | $0 | 8 | 2026-06-18 |
| VERA | Director | — | $32.02 | — | $0 | 6 | 2026-05-26 |
| CRVS | Director | — | $13.86 | — | $0 | 13 | 2025-06-16 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$145.0K | 10 | 2022-10-06 |
| BOLD | Director | — | $2.84 | — | $0 | 5 | 2020-01-15 |
Recent Filings · Page 3 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-17 | VERA | Grant (A) | — | $0 | EDGAR |
| 2023-12-08 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2023-09-19 | TARS | Exer (M) | +1,333 | $0 | EDGAR |
| 2023-06-30 | ZLAB | Grant (A) | +18,903 | $500.0K | EDGAR |
| 2023-06-26 | TARS | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | IDYA | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | VERA | Grant (A) | — | $0 | EDGAR |
| 2022-10-11 | TARS | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −6,637 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.